Publication | Open Access
The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics
236
Citations
21
References
2017
Year
EudraCT number: 2013-004494-28; ClinicalTrials.gov identifier: NCT02065791.
| Year | Citations | |
|---|---|---|
Page 1
Page 1